Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.11% | 4.91% | 6.86% | 45.38% | 47.22% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -100.00% | 199.95% | -- | -- | -- |
| Total Other Non-Cash Items | 140.27% | 104.55% | 32.13% | -99.99% | -97.11% |
| Change in Net Operating Assets | -150.77% | -140.59% | -158.94% | 65.28% | 80.12% |
| Cash from Operations | -37.65% | -22.10% | -7.55% | -9.74% | -2.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -89.80% | -89.80% | -- | -- | -- |
| Total Debt Repaid | -355.19% | -370.15% | -380.25% | -487.79% | -16.02% |
| Issuance of Common Stock | -98.79% | -98.94% | -60.50% | -60.46% | 79.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.47% | 33.65% | 180.68% | 175.44% | 165.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 842.33% | 395.63% | 387.73% | 414.94% | 112.20% |